A mathematical model of HiF-1α-mediated response to hypoxia on the G1/S transition.

Hypoxia is known to influence the cell cycle by increasing the G1 phase duration or by inducing a quiescent state (arrest of cell proliferation). This entry into quiescence is a mean for the cell to escape from hypoxia-induced apoptosis. It is suggested that some cancer cells have gain the advantage over normal cells to easily enter into quiescence when environmental conditions, such as oxygen pressure, are unfavorable [43,1]. This ability contributes in the appearance of highly resistant and aggressive tumor phenotypes [2]. The HiF-1α factor is the key actor of the intracellular hypoxia pathway. As tumor cells undergo chronic hypoxic conditions, HiF-1α is present in higher level in cancer than in normal cells. Besides, it was shown that genetic mutations promoting overstabilization of HiF-1α are a feature of various types of cancers [7]. Finally, it is suggested that the intracellular level of HiF-1α can be related to the aggressiveness of the tumors [53,24,4,10]. However, up to now, mathematical models describing the G1/S transition under hypoxia, did not take into account the HiF-1α factor in the hypoxia pathway. Therefore, we propose a mathematical model of the G1/S transition under hypoxia, which explicitly integrates the HiF-1α pathway. The model reproduces the slowing down of G1 phase under moderate hypoxia, and the entry into quiescence of proliferating cells under severe hypoxia. We show how the inhibition of cyclin D by HiF-1α can induce quiescence; this result provides a theoretical explanation to the experimental observations of Wen et al. (2010) [50]. Thus, our model confirms that hypoxia-induced chemoresistance can be linked, for a part, to the negative regulation of cyclin D by HiF-1α.

[1]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[2]  Y. Ku,et al.  Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1α-Dependent Manner in Pancreatic Cancer Cells , 2011, Pathobiology.

[3]  Chi V. Dang,et al.  Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression* , 2001, The Journal of Biological Chemistry.

[4]  Ming-Tsang Wu,et al.  Hypoxia-inducible Factor-1α is Associated with Risk of Aggressive Behavior and Tumor Angiogenesis in Gastrointestinal Stromal Tumor , 2005 .

[5]  R. Rickert,et al.  Hypoxia-Inducible Factor 1 (cid:2) Is Essential for Cell Cycle Arrest during Hypoxia , 2002 .

[6]  D. Stacey,et al.  Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell , 2006, Cell Division.

[7]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[8]  N. Denko,et al.  Cellular Reaction to Hypoxia: Sensing and Responding to an Adverse Environment , 2005 .

[9]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[10]  R. Rickert,et al.  Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. , 2003, Molecular and cellular biology.

[11]  Gibin G Powathil,et al.  Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model. , 2012, Journal of theoretical biology.

[12]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[13]  W. Pledger,et al.  Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. , 1993, Molecular biology of the cell.

[14]  Attila Csikász-Nagy,et al.  Computational systems biology of the cell cycle , 2009, Briefings Bioinform..

[15]  S. Vasudevan,et al.  MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells , 2012, RNA biology.

[16]  Angélique Stéphanou,et al.  On the importance of the submicrovascular network in a computational model of tumour growth. , 2012, Microvascular research.

[17]  A. Giaccia,et al.  p21Cip1 and p27Kip1Regulate Cell Cycle Reentry after Hypoxic Stress but Are Not Necessary for Hypoxia-Induced Arrest , 2001, Molecular and Cellular Biology.

[18]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[19]  D. Demetrick,et al.  Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. , 2004, Carcinogenesis.

[20]  G. Semenza Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[21]  P. Carmeliet,et al.  Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .

[22]  S. Dower,et al.  Response of tumour cells to hypoxia: role of p53 and NFkB. , 1998, Molecular pathology : MP.

[23]  Inkyoung Lee,et al.  Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death. , 2001, Carcinogenesis.

[24]  L. Rocha-Zavaleta,et al.  Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL , 2013, Leukemia & lymphoma.

[25]  John J Tyson,et al.  A model for restriction point control of the mammalian cell cycle. , 2004, Journal of theoretical biology.

[26]  J. Caro,et al.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. , 1997, The Journal of biological chemistry.

[27]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[28]  P. Ratcliffe,et al.  The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. , 2001, Advances in experimental medicine and biology.

[29]  B. Edgar,et al.  Drosophila cyclin D/Cdk4 requires Hif-1 prolyl hydroxylase to drive cell growth. , 2004, Developmental cell.

[30]  G. Semenza,et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. , 1996, The American journal of physiology.

[31]  Z. Dai,et al.  Up-regulation of hypoxia inducible factor-1α by cobalt chloride correlates with proliferation and apoptosis in PC-2 cells , 2012, Journal of Experimental & Clinical Cancer Research.

[32]  Jin Ding,et al.  Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells. , 2010, Cancer research.

[33]  L. Huang,et al.  Hypoxic Suppression of the Cell Cycle Gene CDC25A in Tumor Cells , 2007, Cell cycle.

[34]  G. Semenza Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.

[35]  S. Reed,et al.  Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. , 2006, Molecular cell.

[36]  M. Ihnat,et al.  Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia. , 2007, Cancer letters.

[37]  M. Frontini,et al.  CSB protein is (a direct target of HIF‐1 and) a critical mediator of the hypoxic response , 2008, The EMBO journal.

[38]  Edda Klipp,et al.  Cell Size at S Phase Initiation: An Emergent Property of the G1/S Network , 2007, PLoS Comput. Biol..

[39]  E. Rankin,et al.  The role of hypoxia-inducible factors in tumorigenesis , 2008, Cell Death and Differentiation.

[40]  Paolo P. Provenzano,et al.  Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling , 2011, Journal of Cell Science.

[41]  R. Blasberg,et al.  Real-Time Imaging of HIF-1α Stabilization and Degradation , 2009, PloS one.

[42]  B. Bao,et al.  Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment , 2012, PloS one.

[43]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[44]  H. Tabuchi,et al.  Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through Hypoxia-inducible factor , 2003, Oncogene.

[45]  P. Maini,et al.  A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. , 2004, Journal of theoretical biology.

[46]  B. Edgar,et al.  Drosophila cyclin D/Cdk4 regulates mitochondrial biogenesis and aging and sensitizes animals to hypoxic stress , 2012, Cell cycle.

[47]  R. Johnson,et al.  HIF-1 in cell cycle regulation, apoptosis, and tumor progression. , 2003, Antioxidants & redox signaling.

[48]  Attila Csikász-Nagy,et al.  Analysis of a generic model of eukaryotic cell-cycle regulation. , 2006, Biophysical journal.

[49]  O. Halevy,et al.  Phosphorylation of pRb is required for HGF‐induced muscle cell proliferation and is p27kip1‐dependent , 2002, Journal of cellular physiology.

[50]  Manfred Kunz,et al.  Molecular responses to hypoxia in tumor cells , 2003, Molecular Cancer.

[51]  Max Costa,et al.  Hypoxia-Inducible Factor-1 (HIF-1) , 2006, Molecular Pharmacology.

[52]  D. Stacey Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. , 2003, Current opinion in cell biology.

[53]  Margaret Ashcroft,et al.  Negative and positive regulation of HIF-1: a complex network. , 2005, Biochimica et biophysica acta.

[54]  H. Jensen,et al.  Quiescence: a mechanism for escaping the effects of drug on cell populations , 2010, Journal of The Royal Society Interface.

[55]  J. Tyson,et al.  Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. , 2001, Journal of theoretical biology.

[56]  R. Moon,et al.  Assessment of Hypoxia Inducible Factor Levels in Cancer Cell Lines upon Hypoxic Induction Using a Novel Reporter Construct , 2011, PloS one.